Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
11/2005
11/03/2005US20050245503 Therapeutic heterocycles
11/03/2005US20050245500 Beta-ketoamide compounds with MCH antagonistic activity
11/03/2005CA2563180A1 Non-nucleoside reverse transcriptase inhibitors
11/02/2005EP1590344A2 Anti-cancer medicaments
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1590338A2 Modulators of melanocortin receptor
11/02/2005EP1590323A2 Piperazine derivatives and their use as synthesis intermediates
11/02/2005EP1590322A1 Carbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof
11/02/2005EP1590314A2 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
11/02/2005EP1334084A4 Phosgene-free process for preparing carbamates
11/02/2005EP1309540B1 Oxidizing colorant
11/02/2005EP1278719B1 Naphthamide neurokinin antagonists for use as medicaments
11/02/2005EP1196371B1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
11/02/2005EP1159261B1 Antizyme modulators and their use
11/02/2005CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
11/02/2005CN1692105A Cetirizine dihydrochloride polymorph and preparation method thereof
11/02/2005CN1690052A Piperazine derivatives and their use in the preparation of quinolone derivatives
11/02/2005CN1690041A Novel derivatives of 3, 3-diphenylpropylamines
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
11/01/2005US6960665 Process for arylating or vinylating or alkynating a nucleophilic compound
11/01/2005US6960614 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids
11/01/2005US6960612 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/01/2005US6960588 Tryptase inhibitors
11/01/2005US6960579 administering a compound containing a biheterocylic ring with sulfonamide group: sleeping disorder, depression, anxiety, circadian rhythm disorders
11/01/2005US6960355 Modified amino acid compounds useful in delivery of active agents
10/2005
10/27/2005WO2005100505A1 New organic luminescent element
10/27/2005WO2005100345A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
10/27/2005WO2005100334A1 Dipeptidyl peptidase-iv inhibitors
10/27/2005WO2005100325A1 Aryl glycinamide derivatives and their use as nk1 antagonists and serotonin reuptake inhibithors
10/27/2005WO2005100324A1 2- ( arylalkoxy ) -1- phenylethylamine derivatives as nk1 antagonist and serotonin reuptake inhibitors
10/27/2005WO2005100311A1 Bicyclic aromatic sulfinyl derivatives
10/27/2005WO2005100310A1 Thio-substituted arylmethanesulfinyl derivatives
10/27/2005WO2005100308A1 Thio-substituted biaryl-methanesulfinyl derivatives
10/27/2005WO2005100303A1 Indene derivatives and process for the preparation thereof
10/27/2005WO2005100297A1 Indene derivatives and process for the preparation thereof
10/27/2005WO2005100292A1 New photoinitiators
10/27/2005WO2005099353A2 A novel process for the preparation of linezolid and related compounds
10/27/2005WO2005090295A3 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
10/27/2005WO2005034848A3 Inhibitors of cathepsin s
10/27/2005WO2004113275A3 Methods and compositions for treating amyloid-related diseases
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
10/27/2005US20050240018 Process for the production of n-(2,6-dimethyl-phenyl)-2-piperazin-1-yl-acetamide
10/27/2005US20050240017 5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-5,11-dihydro-6-oxa-12-thia-dibenzo[a,f]azulen-2-ol; 13-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-7,13-dihydro-12-oxa-benzo[4,5]cyclohepta[1,2-a]naphthalen-3-ol or derivatives or salts; for alleviating symptoms of estrogen deprivation, including bone loss
10/27/2005US20050239881 viricides; polymerase inhibitors; therapy for genetic engineered virus
10/27/2005US20050239870 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; aminoalkylamide, piperidine-, indole-, or pyrrole-amide derivatives; anticarcinogenic agents
10/27/2005US20050239869 calcium atorvastatin (Lipitor) intermediate; from intermediate 5-(4-fluorophenyl)-2-isopropyl-1-(3-morpholin-4-yl-3-oxo-propyl)-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide; via diol esters from the 1,3,5-tricarbonyl precursors in a stereoselective ruthenium-catalyzed hydrogenation (patent indexing)
10/27/2005US20050239862 Amino ceramide-like compounds and therapeutic methods of use
10/27/2005US20050239849 Substituted phenoxyacetic acids
10/27/2005US20050239839 Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
10/27/2005US20050239802 E.g., 6-{2-[5-Chloro-2-(2,4-difluorobenzyloxy)- phenyl]cyclopent-1-enyl}-pyridine-2-carboxylic acid, used to treat prostaglandin mediated diseases that include inflammatory, neuropathic or visceral pain
10/27/2005US20050239799 1-phenyl-4-benzylpiperazines dopamine receptor subtype
10/27/2005US20050238614 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids
10/27/2005CA2562554A1 Thio-substituted arylmethanesulfinyl derivatives
10/27/2005CA2562401A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
10/27/2005CA2561555A1 Bicyclic aromatic sulfinyl derivatives
10/26/2005EP1589016A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
10/26/2005EP1589008A1 A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent
10/26/2005EP1589001A1 Tricyclic aromatic and bis-phenyl sulfinyl derivatives
10/26/2005EP1589000A2 (R)-Chiral halogenated 1-substitutedamino-(N+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
10/26/2005EP1588145A2 Methods, mixtures, kits and compositions pertaining to analyte determination
10/26/2005EP1587518A2 Antineoplastic ether lipid compounds with modifications at the sn-3 carbon
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1183229B1 Glucagon antagonists/inverse agonists
10/26/2005EP1098870B1 Nitrate salt of Cetirizine
10/26/2005CN1688545A Phosphodiesterase 4 inhibitors, including n-substituted phenylamine and diphenylamine analogs
10/26/2005CN1688527A Fused benzene derivative and use
10/26/2005CN1688298A Composition, synthesis and therapeutic applications of polyamines
10/26/2005CN1687042A Technique for producing N-formyl morpholine
10/26/2005CN1687041A Method for synthesizing piperazine
10/26/2005CN1224612C Acetylenic sulfonamide thiol TACE inhibitors
10/26/2005CN1224598C Naphthalene derivatives
10/25/2005US6958352 Compounds for inhibiting insulin secretion and methods related thereto
10/25/2005US6958331 sulfonyl amine derivatives such as {2-(2,2-diphenyl-ethylamino)-5-[4-(4-isopropyl-piperazine-1-carbonyl)-piperidine-1-sulfonyl]-phenyl}-morpholin-4-yl-methanone; pain, inflammation, septic shock
10/25/2005US6958243 Organic reactions with CO generating materials
10/25/2005US6958205 Image forming material and ammonium compound
10/25/2005CA2332461C New benzenesulfonamide derivatives, their method of preparation and the pharmaceutical compositions containing them
10/25/2005CA2331053C Compositions and methods for treating conditions responsive to estrogen
10/25/2005CA2331009C Compositions and methods of treatment for conditions responsive to testosterone elevation
10/25/2005CA2261725C Piperidine and piperazine derivatives and their use as muscarinic antagonists
10/25/2005CA2245490C 3,4-disubstituted phenylethanolaminotetralincarboxamide derivatives
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/20/2005WO2005097779A1 Diarylamine derivatives as calcium channel blockers
10/20/2005WO2005097203A2 Serum protein conjugates of ion channel modulating compounds and uses thereof
10/20/2005WO2005097092A1 Compound with vitamin k activity, particularly as additive for feeds, and preparation of the compound
10/20/2005WO2005049561A3 Processes for preparing novel methylene blue derivative
10/20/2005US20050234265 2-aminomethyl-5-tert-butyl-3-phenylphenol; antimalaria; used against protozoa of the genus Plasmodium, particularly emerging strains of drug-resistant Plasmodia
10/20/2005US20050234125 Alpha-sulfonylamino-acetonitriles
10/20/2005US20050234109 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005US20050234065 Dipeptidyl peptidase-IV inhibitors
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050234058 Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
10/20/2005US20050234050 Ph sensitive prodrugs of 2,6-diisopropylphenol
10/20/2005US20050234046 Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders
10/20/2005US20050233943 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
10/20/2005CA2562371A1 Diarylamine derivatives as calcium channel blockers
10/19/2005EP1586561A1 Bicyclic aromatic sulfinyl derivatives
10/19/2005EP1586560A1 Thio-substituted arylmethanesulfinyl derivatives
10/19/2005EP1586559A1 Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
10/19/2005EP1586558A2 Bis-sulfonamide hydroxyethylamino retroviral protease inhinitors
1 ... 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 ... 341